← Back to headlines
CareDx Highlights 39% Q1 Growth and Naveris Oncology Push at Jefferies Conference
CareDx presented at the Jefferies conference, emphasizing its 39% growth in the first quarter and its strategic push into oncology with Naveris. The presentation detailed the company's financial performance and future growth initiatives in the medical sector.
7 Jun, 10:03 — 7 Jun, 10:03
Sources
Showing 1 of 1 sources
Related Stories
Banks Pause Sales of Products Linked to Mark Walter Amid Investigations
57m ago
Rating Agencies Maintain Stable Outlooks for French and Portuguese Sovereign Debt
1h ago
Canada’s Economy Rebounds With 3.3% Growth in Second Quarter
1h ago
FDA Approves Takeda's Mimrylo for Blood Cancer Condition Polycythemia Vera
1h ago